Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The history of neuromyelitis optica.
Multiple sclerosis susceptibility loci do not alter clinical and MRI outcomes in clinically isolated syndrome.
Natalizumab-related anaphylactoid reactions in MS patients are associated with HLA class II alleles.
Aggressive multiple sclerosis: proposed definition and treatment algorithm.
Regional but Not Global Brain Damage Contributes to Fatigue in Multiple Sclerosis.
Clonal Expansion of Mitochondrial DNA Deletions and the Progression of Multiple Sclerosis.
[Treatment of nausea and vomiting with 5HT3 receptor antagonists, steroids, antihistamines, anticholinergics, somatostatinantagonists, benzodiazepines and cannabinoids in palliative care patients : A systematic review.]
T Cell Epitope Mapping of JC Polyoma Virus-Encoded Proteome Reveals Reduced T Cell Responses in HLA-DRB1*04:01+ Donors.
Network-Based Multiple Sclerosis Pathway Analysis with GWAS Data from 15,000 Cases and 30,000 Controls.
A validated regulatory network for Th17 cell specification.
Fingolimod Increases CD39-Expressing Regulatory T Cells in Multiple Sclerosis Patients.
Stress, Depression and Antidepressant Treatment Options in Patients Suffering from Multiple Sclerosis.
Hope for a rare disease: eculizumab in neuromyelitis optica.
The effects of robot-assisted gait training in progressive multiple sclerosis: A randomized controlled trial.
Neuroprotection With Phenytoin in Optic Neuritis
No association of IFI16 (interferon-inducible protein 16) variants with susceptibility to multiple sclerosis.
Soluble adenylyl cyclase is necessary and sufficient to overcome the block of axonal growth by myelin-associated factors.
The Opioid System and Brain Development: Effects of Methadone on the Oligodendrocyte Lineage and the Early Stages of Myelination.
Recommendations for the detection and therapeutic management of cognitive impairment in multiple sclerosis.
The life extension protein Klotho enhances remyelination following cuprizone-induced demyelination
Long-term safety and efficacy of dalfampridine for walking impairment in patients with multiple sclerosis: Results of open-label extensions of two Phase 3 clinical trials.
Multiple sclerosis, cannabis, and cognition: A structural MRI study.
Alcohol as a Modifiable Lifestyle Factor Affecting Multiple Sclerosis Risk.
Brain MRI of nasal MOG therapeutic effect in relapsing-progressive EAE.
Teaching NeuroImages: MRI time lag with acute disseminated encephalomyelitis.

Pages